Bayban Purchases Shares of 40,639 UnitedHealth Group Incorporated $UNH

Bayban bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, Holdings Channel reports. The firm bought 40,639 shares of the healthcare conglomerate’s stock, valued at approximately $13,415,000. UnitedHealth Group accounts for about 11.9% of Bayban’s investment portfolio, making the stock its largest holding.

Several other institutional investors have also added to or reduced their stakes in the company. AG Campbell Advisory LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $918,000. Rehmann Capital Advisory Group boosted its position in shares of UnitedHealth Group by 1.6% in the fourth quarter. Rehmann Capital Advisory Group now owns 9,215 shares of the healthcare conglomerate’s stock valued at $3,044,000 after acquiring an additional 149 shares during the period. SHP Wealth Management bought a new position in UnitedHealth Group during the fourth quarter worth about $714,000. Employees Provident Fund Board acquired a new stake in UnitedHealth Group in the 4th quarter worth about $99,033,000. Finally, EJMK Ventures LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $217,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $400.86 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $415.98. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The business has a fifty day simple moving average of $373.69 and a 200 day simple moving average of $329.55. The company has a market cap of $364.04 billion, a P/E ratio of 30.28, a P/E/G ratio of 1.61 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter in the previous year, the firm earned $7.20 earnings per share. The business’s quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 18.32 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th will be issued a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is presently 70.09%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on UNH. Erste Group Bank upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, April 27th. Jefferies Financial Group lifted their price objective on UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a report on Monday, April 20th. Sanford C. Bernstein raised their price target on UnitedHealth Group from $444.00 to $492.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 27th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $395.00 to $453.00 and gave the stock an “overweight” rating in a research report on Thursday, June 4th. Finally, Mizuho raised their target price on shares of UnitedHealth Group from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $409.75.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.